Gilead is facing yet another lawsuit over its TDF-based HIV medications, Viread and Truveda.
The complaint, which was filed in the U.S. District Court, Central District of California, on November 1st (Case No. 18-1865) names four plaintiffs:
All of the plaintiffs were taking the tenofovir-based medications either to manage HIV or prevent the infection. They claim that their injuries were the direct result of their treatment and accuse Gilead of concealing these risks from the public.